Mail

UK markets closed

FTSE 100
8,420.26
-18.39(-0.22%)
FTSE 250
20,749.90
-72.94(-0.35%)
AIM
794.02
+1.52(+0.19%)
GBP/EUR
1.1683
+0.0028(+0.24%)
GBP/USD
1.2705
+0.0034(+0.27%)
Bitcoin GBP
52,673.85
+1,399.59(+2.73%)

9 houses with great-looking gardens

Check out these homes if inspiring outside space tops your property wish list

Ovid Therapeutics Inc. (1OT.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR

Add to watchlist

2.9800

-0.0400

(-1.32%)

At close: 08:02AM CEST

Currency in EUR

Valuation measures⁴

Market cap (intra-day)	213.37M
Enterprise value	144.90M
Trailing P/E	N/A
Forward P/E	N/A
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	490.38
Price/book (mrq)	2.98
Enterprise value/revenue	333.09
Enterprise value/EBITDA	-0.69

Trading information

Stock price history

Beta (5Y monthly)	0.69
52-week change ³	-5.62%
S&P500 52-week change ³	26.36%
52-week high ³	3.6800
52-week low ³	2.4600
50-day moving average ³	2.8180
200-day moving average ³	3.1111

Share statistics

Avg vol (3-month) ³	N/A
Avg vol (10-day) ³	N/A
Shares outstanding ⁵	70.94M
Implied shares outstanding ⁶	73.94M
Float ⁸	40.75M
% held by insiders ¹	15.87%
% held by institutions ¹	62.43%
Shares short ⁴	N/A
Short ratio ⁴	N/A
Short % of float ⁴	N/A
Short % of shares outstanding ⁴	N/A
Shares short (prior month ) ⁴	N/A

Dividends & splits

Forward annual dividend rate ⁴	N/A
Forward annual dividend yield ⁴	N/A
Trailing annual dividend rate ³	0.00
Trailing annual dividend yield ³	0.00%
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	0.00%
Dividend date ³	N/A
Ex-dividend date ⁴	N/A
Last split factor ²	N/A
Last split date ³	N/A

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends	31 Dec 2023
Most-recent quarter (mrq)	31 Mar 2024

Profitability

Profit margin	0.00%
Operating margin (ttm)	-11,768.24%

Management effectiveness

Return on assets (ttm)	-28.09%
Return on equity (ttm)	-50.87%

Income statement

Revenue (ttm)	473.69k
Revenue per share (ttm)	0.01
Quarterly revenue growth (yoy)	124.20%
Gross profit (ttm)	N/A
EBITDA	-61.25M
Net income avi to common (ttm)	-50.68M
Diluted EPS (ttm)	-0.6600
Quarterly earnings growth (yoy)	N/A

Balance sheet

Total cash (mrq)	90.26M
Total cash per share (mrq)	1.27
Total debt (mrq)	15.7M
Total debt/equity (mrq)	20.05%
Current ratio (mrq)	10.47
Book value per share (mrq)	1.11

Cash flow statement

Operating cash flow (ttm)	-50.35M
Levered free cash flow (ttm)	-29.24M